Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay
about
Buprenorphine: a unique drug with complex pharmacologyPharmacology of nociceptin and its receptor: a novel therapeutic targetThe nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medicationsNociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain(8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4. 5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist.Transdermal buprenorphine - a critical appraisal of its role in pain management.BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor systemPharmacological enhancement of naltrexone treatment for opioid dependence: a reviewStructural determinants of opioid and NOP receptor activity in derivatives of buprenorphineOpiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Agonist-antagonist combinations in opioid dependence: a translational approachActivities of mixed NOP and mu-opioid receptor ligands.Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphineTranslational approach to develop novel medications on alcohol addiction: focus on neuropeptides.Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference.Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.
P2860
Q24642980-D46A0614-D61B-42E1-A69C-09BBB5E5DDA6Q24675084-06D26724-7359-4222-9EE1-D89D6037B56DQ28297686-99781CF6-7757-4F22-B3F2-4A7F70F4B261Q28350175-D16770DA-569C-4FED-8E8B-971173515084Q33923177-76BB0BDB-9474-44BE-BF6F-11914DFFD793Q34418193-6A062268-C745-47C5-BE5F-4A7270C3C847Q34423181-4BC4B27E-653D-4339-BC77-13FC68C69976Q34561447-0611BCC1-D7D6-4B17-B4CA-C92F6844FB45Q35084340-BBA3B355-1E55-4A5E-8F2E-0577762DF477Q35284997-54EF352A-6B53-4C25-BCF6-91B12393073EQ35763921-4B1B2FBE-BC8D-4F32-BED7-3AE5511FD996Q35848930-5FE71E30-9B40-4832-91F0-3EF27B0FDE42Q36456876-43372A5F-5050-4EB8-BE9C-432B47ACF277Q36744366-275684E6-B343-4B93-AC2E-2BBBC1E533AFQ37073555-77DBDBCD-15B4-4B12-8F2D-B737FD3AC73FQ37076193-20DD85D1-D2D1-4B14-B3F4-CF496B937170Q37290396-456244D8-C763-4FC9-A4BC-59AC71DE5571Q37397573-A65D64F5-A55A-461D-8E32-719F642C9A5DQ37444462-5703F2E6-689E-47ED-A98A-E4D5103ACE8AQ38344663-47746A58-8F5F-400E-ABC7-8718FB2DE568Q38716082-2D06C4AB-2F7D-42CC-9DE6-BC0A497B7B94Q42126097-46B8FC75-CE61-419C-80B0-29085CC90546Q42566902-EBA6026F-80FC-4CD4-91C6-7F220EE1A3F3
P2860
Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@ast
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en-gb
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@nl
type
label
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@ast
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en-gb
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@nl
prefLabel
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@ast
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en-gb
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@nl
P2093
P921
P356
P1476
Agonistic effect of buprenorph ...... -triggered reporter gene assay
@en
P2093
D Hildebrandt
W Englberger
P304
P356
10.1124/MOL.56.2.334
P407
P577
1999-08-01T00:00:00Z